Medicine and Dentistry
Diet Induced Obesity
100%
Lipid Diet
73%
Insulin Resistance
39%
Fatty Liver
37%
Water-Electrolyte Imbalance
29%
Obesity
24%
Dyslipidemia
23%
White Adipose Tissue
22%
Adipose Tissue
17%
Fibrosis
17%
Energy Expenditure
16%
Supplementation
15%
Sarcopenia
13%
Metabolic Syndrome
11%
Adipocyte
10%
Fatty Acid Oxidation
10%
Diabetes
9%
Metabolism
9%
Luteolin
9%
Nonalcoholic Fatty Liver
9%
Lipid Storage
9%
Sodium Intake
8%
Hyperglycemia
8%
Transcriptome
8%
Protein Hydrolysate
7%
Awareness
7%
Uric Acid
7%
Adolescent
7%
Urinary System
7%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
7%
Lipid Metabolism
7%
Gene Expression
7%
Body Weight
7%
Atherosclerosis
6%
Extracellular Matrix
6%
Alcohol
6%
Adipocytokine
6%
Body Fat Mass
6%
Lipogenesis
6%
Nutritional Genomics
5%
Protein Expression
5%
Oriental Herbal Medicine
5%
Weight Management
5%
Microbiome
5%
Protein Degradation
5%
Lipid Metabolism
5%
Hyperuricemia
5%
Body Weight Gain
5%
Therapeutic Procedure
5%
Skeletal Muscle
5%
Biochemistry, Genetics and Molecular Biology
Mouse
85%
Mouse Mutant
43%
Lipid Metabolism
28%
Insulin Resistance
25%
C57BL 6 Mouse
21%
Energy Expenditure
18%
Luteolin
17%
Insulin Resistance
16%
Body Fat
16%
Microarrays
16%
Lipogenesis
15%
Messenger RNA
14%
Blood Lipids
12%
Lipid Storage
12%
Gene Expression
12%
Transcriptome
12%
Adipocyte
12%
Beta Oxidation
12%
Glucose Blood Level
12%
Gluconeogenesis
10%
Flavonoid
9%
Resveratrol
8%
Alpha Oxidation
8%
Signal Transduction
8%
Homeostasis
8%
Lipid Liver Level
8%
Cholesterol Blood Level
8%
Extract
7%
Dyslipidemia
7%
Dyslipidemia
7%
Lipid
7%
Ferulic Acid
7%
Lipid Profile
7%
Body Weight Gain
7%
Skeletal Muscle
7%
Triglyceride
6%
Fat Mass
6%
Metabolic Pathway
6%
Insulin Sensitivity
6%
Mouse Model
6%
Clofibrate
6%
Protein Catabolism
6%
Body Weight
6%
Proinflammatory Cytokine
6%
Db/Db Mouse
5%
Nutritional Genomics
5%
Adipocyte
5%
Leptin
5%
Metabolic Disorder
5%
Adiponectin
5%
Randomized Controlled Trial
5%
Enzyme
5%
Glucose Metabolism
5%
Pharmacology, Toxicology and Pharmaceutical Science
Diet Induced Obesity
63%
Mouse
62%
Fatty Liver
38%
Insulin Resistance
24%
Obesity
23%
Luteolin
20%
Metabolic Disorder
17%
Fatty Acid
16%
Insulin Resistance
15%
Inflammation
14%
Psicose
13%
Metabolic Syndrome X
13%
Antioxidant
10%
Dyslipidemia
10%
Nonalcoholic Fatty Liver
9%
Placebo
9%
Flavonoid
8%
C57BL 6 Mouse
8%
Sarcopenia
7%
Ursolic Acid
7%
Platycodon
7%
Resveratrol
7%
Randomized Controlled Trial
7%
Fibrosis
7%
Hyperglycemia
7%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
7%
Anti-Inflammatory Drug
7%
Inflammation
6%
Db/Db Mouse
5%
Diabetes Mellitus
5%
Messenger RNA
5%
Adipocytokine
5%
High Density Lipoprotein Cholesterol
5%
Mouse Mutant
5%